COMMUNIQUÉS West-GlobeNewswire

Transactions under Novozymes’ stock buyback program

20/08/2018 - 13:39

Please read the full announcement in the attached PDF Attachment 2018_50_Stock_Buybackprogram_EN

European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo™

20/08/2018 - 13:30

MONTREAL, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that the Paediatric Committee of the European Medicines Agency (“EMA”) has accepted to defer the initiation [...]

L’Agence européenne des médicaments autorise le report du plan d’investigation pédiatrique pour Trogarzo(MC)

20/08/2018 - 13:30

MONTRÉAL, 20 août 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd’hui que le comité pédiatrique de l’Agence européenne des médicaments (« AEM ») a accepté de reporter l’ [...]

Trading by management and close relations of management

20/08/2018 - 13:25

Read the full announcement in the attached file Attachment 2018_49_Trading_by_management_EN

Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours

20/08/2018 - 13:00

PRESS RELEASE Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours Study of IMCnyeso in NSCLC, Bladder Cancer, Melanoma and Synovial Sarcoma is the first in GSK collaboration (Oxford, UK [...]

RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation

20/08/2018 - 13:00

Once granted, the new formulation patent is expected to be valid until at least 2033 RHB-106 is an encapsulated bowel preparation with worldwide rights licensed to Salix Pharmaceuticals RedHill and Salix recently [...]

iKang Announces Shareholders’ Approval of “Going Private” Transaction

20/08/2018 - 12:59

BEIJING, Aug. 20, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]

Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Services Business in Massachusetts, U.S.

20/08/2018 - 12:45

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 20, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), is [...]

Novan Announces Promising Clinical Results with SB414

20/08/2018 - 12:30

In the recently completed Phase 1b trial for atopic dermatitis, clinical efficacy measures were highly correlated with critical and disease-relevant biomarker changes suggesting a topical nitric oxide therapeutic has [...]

Syneos Health™ Acquires Kinapse to Further Enhance End-to-End Capabilities

20/08/2018 - 12:20

Addition of Market Leading Advisory and Operational Solutions Provider Increases High-Value Offerings and Expands Operational Scale in Key Growth Markets RALEIGH, N.C., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Syneos Health, [...]

Try “Eat an Apple Day” Instead of “Cream Filled Donut Day” For Optimal Dental Health Says Hillcrest Dentist Dr. Doug Disraeli

20/08/2018 - 12:00

SAN DIEGO, Aug. 20, 2018 (GLOBE NEWSWIRE) -- With observances in September including “Ice Cream Cone Day,” “Cream Filled Donut Day,” “Blueberry Popsicle Day,” and “Chocolate Day,” Dr. Doug Disraeli reminds San Diegans [...]

ViroGates Announces The Launch Of The First suPARnostic® TurbiLatex Product

20/08/2018 - 11:30

Company announcement no. 6-2018 Birkerød, 20 August 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency departments in hospitals, today announces that it has [...]

HealthLynked Corp. Announces Release of its Android App and New Features for Mobile Users

20/08/2018 - 11:00

NAPLES, Fla., Aug. 20, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (the “Company”) (OTCQB: HLYK) today announced the launch of its mobile app for Android™ mobile devices that connects patients (users/members) with their [...]

Oral semaglutide provides superior HbA1c and weight reductions versus placebo in people with type 2 diabetes and renal impairment in the PIONEER 5 trial

20/08/2018 - 10:57

Bagsværd, Denmark, 20 August 2018 - Novo Nordisk today announced the headline results from PIONEER 5, a phase 3a trial with oral semaglutide in adults with type 2 diabetes and moderate renal impairment. Oral semaglutide [...]

AC Immune Announces Important Clinical Milestones for ACI-24 Vaccine in Alzheimer's Disease and Down Syndrome

20/08/2018 - 10:01

Start of Phase 2 trial with ACI-24 in patients with mild Alzheimer's disease; first patient enrolled Recruitment completed for high-dose cohort of Phase 1b study with ACI-24 for Abeta-related cognitive decline in [...]

PCI Biotech initiates research collaboration with Bavarian Nordic

20/08/2018 - 09:00

Exploring synergies between proprietary technologies to further enhance the effect of novel therapeutic applications in cancer and infectious diseases Oslo (Norway) 20 August 2018 — PCI Biotech (OSE: PCIB), a cancer [...]

FIT Biotech Oy: Correction to company release dated August 16th, 2018: Chairman of the board on leave of absence

20/08/2018 - 08:51

FIT Biotech Oy Company release 20.8.2018 at 10:00 AM EET Correction to company release dated August 16 th , 2018: Chairman of the board on leave of absence On the company release on August 16, 2018 there was an [...]

ASLAN Pharmaceuticals Granted Orphan Drug Designation by the FDA for ASLAN003 for the Treatment of Acute Myeloid Leukaemia

20/08/2018 - 08:49

SINGAPORE, Aug. 20, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]

Olainfarm Group seven-month sales increase by 4%.

20/08/2018 - 08:09

Consolidated Results of 7 months 2018 Preliminary consolidated Olainfarm Group sales results of seven months of 2018 show an increase of 4% in comparison to the corresponding period of 2017 and reached 70.6 million [...]